Evaluation of the Response to Irradiation With MR-Spectroscopy for Localised Prostate Cancer Patients (The ERIS Trial)
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
PSA value compare to Choline and Citrate levels as measured with MR-spectroscopic imaging as predictive factor of the response to treatment
Data will be collected at the end of the radiotherapy and every 3 months up to 1 year for each patient. Data analysis will be performed at the end of data completion in december 2011.
up to 1 year
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)